Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11
Phase 21

Trial Status

Completed1
Other1

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT03319745Phase 2Completed
Pembrolizumab in Treating Patients With Bladder Cancer Undergoing Radical Cystectomy
Stage I Bladder Cancer AJCC v8Stage II Bladder Cancer AJCC v8Stage III Bladder Cancer AJCC v8+2 more
PrincipalinvestigatorStart date: 2018-01-11

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Dean Bajorin, MD

Memorial Sloan Kettering Cancer Center

Related
9 trials

Shared therapeutic areas:

Urinary Bladder CancerUrinary Bladder

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score9%

Lung-Ji Chang, PhD

Shenzhen Geno-Immune Medical Institute

Related
18 trials

Shared therapeutic areas:

Urinary Bladder Cancer
Similarity Score4%

Jitendra Amlani, MD

Urocare Hospital

Related
2 trials

Shared therapeutic areas:

Urinary Bladder Cancer
Similarity Score4%

Gustavo Leone

Medical University of South Carolina, Hollings Cancer Center

Related
12 trials

Shared therapeutic areas:

Urinary Bladder Cancer
Similarity Score4%

Steven A Rosenberg, M.D.

National Cancer Institute (NCI)

Related
32 trials

Shared therapeutic areas:

Urinary Bladder Cancer

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score4%

Andrea B Apolo, M.D.

National Cancer Institute (NCI)

Related
12 trials

Shared therapeutic areas:

Urinary Bladder Cancer

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score4%

Sushil Bhatia, MD

Choithram Hospital and Research Centre

Related
2 trials

Shared therapeutic areas:

Urinary Bladder Cancer
Similarity Score4%

Dean F. Bajorin, MD

Memorial Sloan Kettering Cancer Center

Related
8 trials

Shared therapeutic areas:

Urinary Bladder Cancer

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score4%

Yoshiya Yamada, MD

Memorial Sloan Kettering Cancer Center

Related
9 trials

Shared therapeutic areas:

Urinary Bladder Cancer
Similarity Score4%

Laurence H. Klotz, MD

Toronto Sunnybrook Regional Cancer Centre

Related
5 trials

Shared therapeutic areas:

Urinary Bladder Cancer

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score4%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT05055050Phase 1PrincipalInvestigator

A Window of Opportunity Phase I Study of UGN-201 in Patients With Bladder Cancer Undergoing Radical Cystectomy Protocol #: 2021-0630

BladderBladder Cancer
Active Not Recruiting
NCT03319745Phase 2PrincipalInvestigator

Pembrolizumab in Treating Patients With Bladder Cancer Undergoing Radical Cystectomy

Stage I Bladder Cancer AJCC v8Stage II Bladder Cancer AJCC v8Stage III Bladder Cancer AJCC v8+2 more
Completed

All 2 trials loaded